XNAS: RNTX
Rein Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Rein Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing novel therapies for the treatment of orphan pulmonary and fibrosis indications with no approved or limited effective treatments. Its pipeline includes: LTI-03, ...
Read More
1.02
-0.01
(-0.97%)
1.7M
XNAS Volume
High volume today
XNAS 04 May, 2026 4:17 PM (EDT)
Board Meeting
The next board meeting for Rein Therapeutics Inc is on 15 May 2026 for the purpose of Rein Therapeutics Inc First Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Neutral
Rein Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..